Applied Clinical Trials Online12h
Phase I Trial Supports Development of Once-Yearly Lenacapavir as Long-Acting HIV PrEP Option
Phase I trial results show the potential of once-yearly lenacapavir as a long-acting PrEP option for HIV, supporting further ...
Medscape16h
Antiretrovirals Alone Don’t Delay Language Development in Exposed Children
Children exposed to antiretroviral (ARV) therapy in utero and not exposed to HIV showed no difference in language development at 5 years of age compared with unexposed children, based on new data from ...
Scientists develop yearly HIV injection: How it could help millions
HIV prevention has advanced with lenacapavir, a yearly injection that blocks the virus's replication, providing long-term ...
Dog Bite? Rabies Vaccine Shots Alone Won’t Save You—Here’s What You Must Do Next
Rabies is a deadly disease that spreads through animal bites, mostly from dogs. Experts warn that just getting a vaccine may not be enough—some cases need rabies immunoglobulin (RIG) for protection., ...
AllAfrica21h
Uganda: Annual HIV Prevention Jab Shows Promise - What It Means for Uganda
A groundbreaking annual injection designed to protect against HIV has successfully passed its first safety trial, bringing new hope for long-term prevention.